Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

More than 5,100 adults ages 18-30 were recruited for the 'Coronary Artery Risk Development in Young Adults' (CARDIA) study, which began in the mid-1980s, and were followed up until 2020.

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment ...

Coronary artery disease is a widespread and serious condition, affecting 1 in 20 adults age 20 and older. But manypeople ...

A normal coronary angiogram does not always guarantee safety from a heart attack. Conditions like microvascular disease, ...

Heart specialists in our area and across the U.S. are noting a concerning shift: heart disease is increasingly affecting ...

New study reveals men face heart attack risk seven years earlier than women, starting in mid-30s. Northwestern research ...

Recent developments in reimbursement and insurer coverage for plaque analysis in the US are a step towards the evaluative ...

Background: Middle-aged and older endurance athletes have increased prevalence of coronary artery disease (CAD) on coronary CT angiography (CCTA) compared to healthy controls, despite similarly low ...

Men begin developing heart disease up to seven years earlier than women, a 30-year US study finds, with risk diverging sharply from the mid-30s, underscoring the need for earlier screening.

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart ...